CytoSorb Therapy to Treat Critically Ill COVID-19 Patients CytoSorb Therapy to Treat Critically Ill COVID-19 Patients

This report suggests that CytoSorb, an extracorporeal cytokine adsorber that reduces inflammatory mediators in the blood, holds promise in treating severely ill patients with COVID-19.Journal of Medical Case Reports
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news